CaseHippo vs MyGlomCon
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
CaseHippo
Access a unified platform for educational content, including courses, events, and academic submissions. Explore detailed abstracts and exhibitor information in one convenient application.
- Explore courses
- View events
- Access abstracts
- Discover exhibitors
- Unified platform
Read full descriptionHide full description
The one stop app for Knowledge Hubs. View and Explore Courses, Events, Abstracts, Submissions, Exhibitors.
MyGlomCon
This app connects nephrologists and nephropathologists to advance glomerular disease care. Access a vast archive of lectures and seminars, participate in professional forums, and find fellowship content.
- Glomerular disease care advancement
- Archive of lectures and seminars
- Professional discussion forum
- Access to fellowship content
- Global network connectivity
Read full descriptionHide full description
Our goal is to enable our global network of nephrologists and nephropathologists to come together and define the future of glomerular disease care. GlomCon is a nonprofit, charitable 501c(3) organization, registered in the U.S. Every GlomCon Lecture GlomCon Seminars started in 2016 as virtual multidisciplinary seminars that included case discussions and lectures by world-renowned experts. Due to the outstanding learning experience provided by the exceptional faculty and speakers, GlomCon Seminars grew from a small virtual community of nephrologists in Boston to a weekly event with global participants from over 130 countries. This App provides access to the entire archive and more. Professional Forum A closed corner for healthcare professionals to exchange experience, and discuss the latest evidence, clinical trials, and diagnostic or treatment opportunities. Courses and Fellowship This App also provides access to KPCP and GlomCon Fellowship content to those who have successfully enrolled in those courses.
Screenshots
Verdict
The clearest difference is in-app purchases: CaseHippo at none against MyGlomCon's 1. CaseHippo also leads on iOS requirement (13.0 vs 15.1). MyGlomCon's advantage is update cadence (every 5 weeks vs every 3 months). On price, rating, ratings volume and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. MyGlomCon sells 1 one-off in-app purchase. CaseHippo asks for nothing beyond the download.
On the App Store both sit at effectively the same score — 5.0 for CaseHippo against 5.0 for MyGlomCon. Both are backed by a comparable volume of ratings — 1 and 1 respectively.
CaseHippo ships an update every 3 months, MyGlomCon every 5 weeks. The most recent releases landed on October 7, 2026 and October 5, 2026 respectively.
| Parameter | CaseHippo | MyGlomCon |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) | 5.0 (1 ratings) |
| Number of ratings | 1 | 1 |
| Update frequency | Every 3 months | Every 5 weeks — better |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 74 MB | 79 MB |
| Age rating | 12+ | 17+ |
| Developer | CaseHippo Inc | Glomerular Disease Study and Trial Consortium |
Customer experience
CaseHippo
MyGlomCon
In-app purchases
CaseHippo
No in-app purchases
MyGlomCon
- 2024 Kidney Pathology Cert$690.00
